Progressive Multifocal Leukoencephalopathy
How to Say It: LOO-koh-en-sef-ah-LOP-ah-thee
by Cynthia M. Johnson, MA
Progressive Multifocal Leukoencephalopathy (PML) is a rare disease of the white matter of the brain.
PML is caused by an infection by a specific virus. Many people get this virus as a child, but do not get sick until later. It stays in the body and does not cause problems in most people.
The virus can start to cause problems in people with a weak immune system. It attacks the cells that make the material that insulates nerve cells (neurons).
PML is most common in people who have problems with their immune system. These problems may be from:
PML gets worse over time. Problems may be:
You will be asked about your symptoms and health history. A physical exam will be done.
An MRI scan will be done to look for damage to the brain.
To confirm PML, your doctor may need:
There is no cure. The goal of treatment is to strengthen the immune system to slow harm to the body. Choices are:
The virus that causes PML cannot be prevented. PML may be prevented in people with HIV by taking steps to prevent the immune system from weakening.
AIDS Information, Education, Action
NORD—National Organization for Rare Disorders
Canadian AIDS Society
CORD—Canadian Organization for Rare Disorders
Grebenciucova E, Pruitt A. Infections in patients receiving multiple sclerosis disease-modifying therapies. Curr Neurol Neurosci Rep. 2017;17(11):88.
Progressive multifocal leukoencephalopathy information page. National Institute of Neurological Disorders and Stroke website. Available at https://www.ninds.nih.gov/Disorders/All-Disorders/Progressive-Multifocal-Leukoencephalopathy-Information-Page. Accessed October 2, 2020.
Progressive multifocal leukoencephalopathy. EBSCO DynaMed website. Available at: https://www.dyname... . Accessed October 2, 2020.
Progressive multifocal leukoencephalopathy (PML). AETC National Resource Center website. Available at:
...(Click grey area to select URL)
Accessed October 2, 2020.
Williamson EML, Berger JR. Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies. Neurotherapeutics. 2017 Oct;14(4):961-973.
Last reviewed September 2020 by EBSCO Medical Review Board Rimas Lukas, MD
Last Updated: 10/2/2020
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.